Search

21352
21354
21383
Medicines Information Centre 021 406 6829
A Drug Information Service for Health Professionals provided by specially trained pharmacists. The Medicines Information Centre (MIC) is situated in the Division of Clinical Pharmacology, Department of Medicine at the University of Cape Town's...
MIC
HIV & TB Health Care Worker Hotline
HIV & TB Health Care Worker Hotline
The MIC, in collaboration with the Foundation for Professional Development (FPD) and PEPFAR/USAID, run the National HIV...
HIV & TB HCW Hotline App
The HIV & TB HCW Hotline App provides contact details, information and resources on HIV and TB.

News

Friday, 20 April 2018
We need your help

Established in 1980, the MIC has answered over 200 000 queries from health care workers and we’ve done it well. During this time, the centre has been funded by a range of generous funders. Our current funding, kind favour of the Global Fund and Western Cape Department of Health ends in March 2019, so we’re on the hunt for more generous funders. Please, if you are one of those, or you know of anyone/any organisation that is, let us know.

Publication Date:
Wednesday, March 28, 2018 - 20:30
New Tool: Management of suspected drug-induced rash, kidney injury and liver injury in adult patients on TB treatment and/or antiretroviral treatment

We’re proud to announce our latest publication.

Publication Date:
Wednesday, November 29, 2017 - 16:15
Induction phase for cryptococcal meningitis treatment

Molloy and colleagues in the ACTA trial study team published their results in the New England Journal of Medicine recently. They report that induction therapy for cryptococcal meningitis in the form of amphotericin B and flucytosine for one week, followed by fluconazole plus flucytosine for two weeks was effective in resource-limited settings.

Publication Date:
Wednesday, March 28, 2018 - 20:45
Reducing some antipsychotic doses may actually improve schizophrenia symptoms

Ning and colleagues recently published their research in the Journal of Psychopharmacology. Their study looked at reducing the dose of olanzapine or risperidone in stable schizophrenic patients and the effect on cognitive function and symptoms.

Publication Date:
Wednesday, March 28, 2018 - 20:45